Mongolia - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Mongolia Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases decreased by 5.5% year on year. With 240 Cases in 2019, the country was number 98 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. Mongolia is overtaken by Lithuania, which was number 97 at 246 Cases and is followed by Morocco with 235 Cases. India lead the ranking with 66,255 Cases in 2019, that is +13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 240.00 |
| 2018 | 234.00 |
| 2017 | 220.00 |
| 2016 | 219.00 |
| 2015 | 243.00 |
How does Mongolia rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 97 |
#97
Lithuania
|
246 | 2019 | -2.4 % | -2.5 % | View data | |
| 98 |
#98
Mongolia
|
240 | 2019 | +2.6 % | -5.5 % | View data | |
| 99 |
#99
Morocco
|
235 | 2019 | -18.1 % | +15.4 % | View data | |